In Vitro Diagnostic Test Produces Incorrect Antibiotic Susceptibility Results
Biomerieux's ETEST IMIPENEM RELEBACTAM diagnostic test produces major errors when testing Pseudomonas aeruginosa, incorrectly identifying resistant strains as susceptible. Approximately 1,431 units distributed worldwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA medical device recall where the diagnostic test produces incorrect antibiotic susceptibility results for Pseudomonas aeruginosa, a high-risk pathogen. While no illnesses or injuries have been reported, the risk of diagnostic error leading to inappropriate antibiotic therapy represents significant potential for patient harm.
Plain-English summary
Biomerieux Inc is recalling the ETEST IMIPENEM RELEBACTAM in vitro diagnostic test, which is used to determine bacterial susceptibility to the antibiotic combination imipenem and relebactam.
The recall was issued because the test produces major errors when testing Pseudomonas aeruginosa strains, incorrectly reporting resistant bacteria as susceptible. This diagnostic error could lead to inappropriate antibiotic selection and potentially ineffective treatment.
Approximately 1,431 units have been affected. The test was distributed nationwide across the United States and internationally to Austria, Belgium, Croatia, Czech Republic, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Affected laboratories and healthcare facilities that have received the recalled test should verify lot numbers against the FDA notice and discontinue use of affected units.
The recalled product
- Product
- ETEST IMIPENEM RELEBACTAM. in vitro diagnostic
- Manufacturer
- Biomerieux Inc
- Hazard
- diagnostic-error
- incorrect-susceptibility-result
- pseudomonas-aeruginosa
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Ref 420927 (US Product) Lot numbers 1007888860
- 1008598340
- 1008701580
- 1007607290
- 1007888870
- 1008390030
- 100859840 and 1008701580
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03